HYAL2 and neoplasm: In addition, hyaluronan-enriched stroma supports the transition of tumor-recruited Hyal2<sup>+</sup>MDSCs to the PD-L1<sup>+</sup> tumor-associated macrophages leading to the formation of an immunosuppressive and tolerogenic tumor microenvironment.